Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) EBT Margin: 2015-2025

Historic EBT Margin for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to -332.97%.

  • Editas Medicine's EBT Margin rose 10152932.00% to -332.97% in Q3 2025 from the same period last year, while for Sep 2025 it was -426.12%, marking a year-over-year decrease of 8518.00%. This contributed to the annual value of -733.71% for FY2024, which is 53963.00% down from last year.
  • Per Editas Medicine's latest filing, its EBT Margin stood at -332.97% for Q3 2025, which was up 76.86% from -1,438.71% recorded in Q2 2025.
  • Editas Medicine's EBT Margin's 5-year high stood at -31.41% during Q4 2023, with a 5-year trough of -132,683.33% in Q3 2022.
  • Over the past 3 years, Editas Medicine's median EBT Margin value was -1,395.32% (recorded in 2023), while the average stood at -11,526.91%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by 13,205,237bps in 2022, then soared by 13,183,965bps in 2023.
  • Over the past 5 years, Editas Medicine's EBT Margin (Quarterly) stood at -332.30% in 2021, then tumbled by 59,692bps to -929.22% in 2022, then surged by 89,782bps to -31.41% in 2023, then plummeted by 11,691bps to -148.32% in 2024, then soared by 10,152,932bps to -332.97% in 2025.
  • Its last three reported values are -332.97% in Q3 2025, -1,438.71% for Q2 2025, and -1,624.37% during Q1 2025.